Inhibitors of HCV replication of formula (I) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein Y, R1, R2, R4 and n have the meaning defined in the claims. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy.
公式(I)的HCV复制
抑制剂包括立体
化学异构形式,以及它们的盐、
水合物、溶剂合物,其中Y、R1、R2、R4和n的含义如权利要求中所定义。本发明还涉及制备所述化合物的方法,含有它们的药物组合物以及它们在HCV治疗中的应用。